Russell I Heigh
Mayo Clinic, USA
Title: Cancer in Inflammatory Bowel Disease 2020: From association with disease to its treatment, with leverage points for prevention and early detection
Biography
Biography: Russell I Heigh
Abstract
Inflammatory Bowel Disease, including both Chronic Ulcerative Colitis and Crohns Disease, is a set of commonly encountered clinical conditions. It is estimated that the conditions have prevalence approximately 250-300/100,000 in the USA. Unfortunately, over the last decade the incidence of Inflammatory Bowel Disease is increasing in much of the world. Inflammatory Bowel Disease is associated with both intestinal and extra intestinal malignancies. Some of the therapies frequently used to treat the medical condition are themselves also associated with increased development of malignancies. This discussion will review the current spectrum, status and issues related to the malignancies experienced by patients with Inflammatory Bowel Disease. Additionally, efforts at prevention and early detection of malignancy will be described. Monitoring opportunities, surveillance programs, and the role of the new chromo colonoscopy will be reviewed